Form D · Biotechnology
Evofem Biosciences, Inc.
San Diego, CA · CIK 0001618835
Offering snapshot reported Jul 2, 2025 · SEC filing
- Reported sold
- $925K Offering amount: $925K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 26, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2025 | Initial | $925,000 | No comparison | 1 | SEC filing |
| Apr 15, 2025 | Initial | $750,000 | No comparison | 1 | SEC filing |
| Aug 21, 2024 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Aug 21, 2024 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Oct 11, 2023 | Initial | $2,884,615 | No comparison | 14 | SEC filing |
| Mar 6, 2023 | Initial | $1,384,616 | No comparison | 4 | SEC filing |
| Feb 3, 2023 | Initial | $2,307,693 | No comparison | 8 | SEC filing |
| Oct 16, 2020 | Initial | $25,000,000 | No comparison | 2 | SEC filing |
| May 6, 2020 | Initial | $15,000,000 | No comparison | 2 | SEC filing |
| Apr 22, 2019 | Initial | $30,000,001 | No comparison | 1 | SEC filing |
| Feb 14, 2019 | Initial | $6,300,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-550600
Source: Form D, filed Jul 2, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Russell Barrans | Executive |
| Kelly Cullwell | Executive |
| Kelly Culwell | Executive |
| Justin File | Executive |
| Alexander A. Fitzpatrick | Executive |
| Gillian Greer | Director |
| William Hall | Director |
| Kim Kamdar | Director |
| Thomas Lynch | Director |
| Tony O'brian | Director |
| Tony O'brien | Director |
| Saundra Pelletier | Director, Executive |
| Lisa Rarick | Director |
| Colin Rutherford | Director |
| Jenny Yip | Director |
| Ivy Zhang | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7770 Regents Road Suite 113 618
San Diego, CA, 92122
San Diego, CA, 92122